What is the best medication for a patient with normal blood pressure and a resting heart rate of 70‑80 bpm who experiences palpitations and occasional tachycardia episodes up to 214 bpm?

Best Medication for Palpitations with Rare Episodes of HR 214

For a patient with normal blood pressure, baseline heart rate of 70-80 bpm, and rare episodes of tachycardia reaching 214 bpm, you should first establish the diagnosis with an ECG during symptoms, but empirically start a beta-blocker (such as metoprolol or bisoprolol) as first-line therapy for ongoing management.

Diagnostic Considerations

The heart rate of 214 bpm strongly suggests supraventricular tachycardia (SVT), most likely AVNRT (atrioventricular nodal reentrant tachycardia), which typically presents with rates of 180-200 bpm but can range from 110 to >250 bpm 1. AVNRT is the most common SVT, occurring in >60% of women, and typically presents with sudden onset palpitations 1.

Critical pitfall: You must document the rhythm during an episode before committing to long-term therapy. A 12-lead ECG during tachycardia or event monitor recording is essential to confirm the diagnosis and rule out other mechanisms.

Acute Management Strategy (When Episodes Occur)

If the patient experiences an episode:

1. First-line: Vagal maneuvers - Valsalva maneuver (bearing down for 10-30 seconds) or carotid massage (Class I recommendation) 1

2. Second-line: Adenosine - If vagal maneuvers fail, adenosine terminates AVNRT in ~95% of cases and serves both therapeutic and diagnostic purposes (Class I recommendation) 1, 2

3. Third-line: IV beta-blockers, diltiazem, or verapamil - Reasonable for acute treatment in hemodynamically stable patients (Class IIa) 1

Ongoing Prophylactic Management

For preventing recurrent episodes, the evidence supports:

Beta-Blockers (Preferred First-Line)

• Metoprolol or bisoprolol are the most appropriate choices given normal blood pressure and baseline heart rate
• Bisoprolol 5 mg twice daily has been shown to significantly reduce heart rate and improve quality of life in patients with inappropriate tachycardia, decreasing resting HR from 102±10 to 78±6 bpm 3
• Beta-blockers are particularly suitable because they:
  • Control both resting heart rate and exercise-induced tachycardia
  • Have excellent safety profile in patients with normal BP
  • Reduce symptoms and improve quality of life scores 3

Alternative: Calcium Channel Blockers

• Diltiazem or verapamil are reasonable alternatives if beta-blockers are contraindicated or not tolerated (Class IIa) 1, 4
• These are particularly effective for AVNRT but should be used cautiously if there's any possibility of pre-excitation (WPW syndrome)

Alternative: Ivabradine

• Ivabradine 5 mg twice daily showed equivalent efficacy to bisoprolol in reducing heart rate (102±10 to 74±8 bpm) with similar improvement in quality of life 3
• This is a pure heart rate-lowering agent without negative inotropic effects
• Particularly useful if beta-blockers cause fatigue or other side effects

Definitive Treatment Consideration

Catheter ablation should be strongly considered as it offers:

• Curative therapy for AVNRT with >95% success rate
• Elimination of need for lifelong medication
• Low complication risk in experienced centers
• This is particularly relevant for a young patient with recurrent symptomatic episodes

The ACC/AHA/HRS guidelines support catheter ablation as a reasonable first-line option for patients with recurrent symptomatic SVT 1.

Practical Algorithm

1. Document the rhythm during an episode (event monitor, smartphone ECG, or ER visit)
2. Start beta-blocker (metoprolol 25-50 mg twice daily or bisoprolol 5 mg twice daily)
3. Teach vagal maneuvers for acute episodes
4. Refer to electrophysiologist for consideration of catheter ablation if:
   • Episodes are frequent or severely symptomatic
   • Patient prefers definitive cure over chronic medication
   • Medication is ineffective or not tolerated

Important Caveats

• Avoid verapamil/diltiazem if there's any possibility of pre-excited atrial fibrillation (WPW syndrome), as this can precipitate ventricular fibrillation
• Monitor for bradycardia when initiating beta-blockers, especially given the normal baseline heart rate of 70-80 bpm
• Ensure structural heart disease is excluded before considering class IC agents (flecainide/propafenone), though these are generally second-line options

1, 4, 3